Newborn yeast infection study: which drug works best?
NCT ID NCT02145832
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This study looked at 100 newborns with suspected or confirmed yeast infections (candidiasis) to compare two antifungal drugs: fluconazole (the current standard) and micafungin. The goal was to see if micafungin works just as well and is as safe as fluconazole. Researchers also studied how the drugs behave in the bodies of growing and premature infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Antwerp, Rocourt, Liège, Louvain, Namur, Belgium
-
Study site
Paris, Lyon, Saint-Pierre de La Réunion, France
-
Study site
Roma, Torino, Catania, Foggia, Reggio Emilia, Italy
-
Study site
Rotterdam, Amsterdam, Utrecht, Isala, Netherlands
-
Study site
Malaga, Salamanca, Spain
Conditions
Explore the condition pages connected to this study.